Sign in
BioinformaticsbioRxiv
Preprint

TandemAligner: a new parameter-free framework for fast sequence alignment

Andrey V. BzikadzeiD, Pavel A. PevzneriD

Abstract

The recent advances in "complete genomics" revealed the previously inaccessible genomic regions (such as centromeres) and enabled analysis of their associations with diseases. However, analysis of variations in centromeres, immunoglobulin loci, and other extra-long tandem repeats (ETRs) faces an algorithmic bottleneck since there are currently no tools for accurate sequence comparison of ETRs. Counterintuitively, the classical alignment approaches, such as the Smith-Waterman algorithm, that work well for most sequences, fail to construct biologically adequate alignments of ETRs. This limitation was overlooked in previous studies since the ETR sequences across multiple genomes only became available in the last year. We present TandemAligner -- the first parameter-free sequence alignment algorithm that introduces a sequence-dependent alignment scoring that automatically changes for any pair of compared sequences. We apply TandemAligner to various human centromeres and primate immunoglobulin loci, arrive at the first accurate estimate of the mutation rates in human centromeres, and quantify the extremely high rate of large insertions/duplications in centromeres. This extremely high rate (that the standard alignment algorithms fail to uncover) suggests that centromeres represent the most rapidly evolving regions of the human genome with respect to their structural organization.

02 /Specification & Classification

Click any tag to browse matching papers

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISEizenga '26Wu '26Liao '25Jain '18Yang '25Linthorst '15
60% semantic matchGenomics
Jordan M. Eizenga, Mira Mastoras, Julian Lucas+15 more·bioRxiv·Sep 4, 2026